Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Lichen amyloidosis is a rare chronic form of cutaneous amyloidosis, a skin disease characterized by the accumulation of amyloid deposits in the dermis, clinically characterized by the development of pruritic, often pigmented, hyperkeratotic papules on trunk and extremities, especially on the shins, and histologically by the deposition of amyloid or amyloid-like proteins in the papillary dermis.
Features include very common findings: Pruritus and Papule.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Skin | 2 | Pruritus, Papule |
Phenotype severity distribution: 2 very common features.
No clinical trials have been registered for lichen amyloidosis.
35 publications have been identified in PubMed for lichen amyloidosis. Research spans Case Report / Case Series (49%), Review / Meta-Analysis (14%), and Other (11%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 17 | 49% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:01 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
5 |
14% |
Other research | 4 | 11% |
Laboratory research | 3 | 9% |
Disease patterns and progression | 3 | 9% |
New treatment approaches | 2 | 6% |
Clinical study results | 1 | 3% |
Yasir M (2026). [PMID: 30085596](https://pubmed.ncbi.nlm.nih.gov/30085596/). *Unknown Journal*. [Case Report / Case Series]
Inoue T (2026). [PMID: 41964247](https://pubmed.ncbi.nlm.nih.gov/41964247/). *J Dermatol*. [Case Report / Case Series]
Łabędź N (2026). [PMID: 42194535](https://pubmed.ncbi.nlm.nih.gov/42194535/). *J Clin Med*. [Case Report / Case Series]
Tsai YT (2026). [PMID: 41316943](https://pubmed.ncbi.nlm.nih.gov/41316943/). *Kaohsiung J Med Sci*. [Other]
Pálla S (2026). [PMID: 41165034](https://pubmed.ncbi.nlm.nih.gov/41165034/). *Int J Dermatol*. [Review / Meta-Analysis]
Ghosh SK (2026). [PMID: 42085007](https://pubmed.ncbi.nlm.nih.gov/42085007/). *Indian Dermatol Online J*. [Epidemiology / Natural History]
da Silva TL (2026). [PMID: 42107924](https://pubmed.ncbi.nlm.nih.gov/42107924/). *An Bras Dermatol*. [Gene Therapy / Novel Therapeutics]
Teng Y (2026). [PMID: 42029085](https://pubmed.ncbi.nlm.nih.gov/42029085/). *Int J Dermatol*. [Review / Meta-Analysis]
Fukushima-Nomura A (2025). [PMID: 40456762](https://pubmed.ncbi.nlm.nih.gov/40456762/). *Nat Commun*. [Basic Science / Preclinical]
Hansen AW (2025). [PMID: 39941743](https://pubmed.ncbi.nlm.nih.gov/39941743/). *Cancers (Basel)*. [Epidemiology / Natural History]